PeptideLabs Logo
PeptideLabs
All profiles

SNAP-8

Peptide · Skin & cosmetics

Primarily a cosmetic ingredient. Marketing around wrinkles or expression lines is not an approved medicinal effect.

Not FDA/EMA approved
LibraryNo account · this device only

Also known as: Acetyl octapeptide-3 · Acetyl glutamyl heptapeptide-1

Use at a glance

SNAP-8

Primarily a cosmetic ingredient. Marketing around wrinkles or expression lines is not an approved medicinal effect.

No reliable information available

No sufficiently clear source for amounts, intervals and cycles can be assigned to this profile. Concrete stages are therefore intentionally omitted; an invented number would be more dangerous than a visible data gap.

How is it used?
Topical products and injections must be considered separately. Skincare directions are not injection directions.
Does it need mixing?
There is no general injection-mixing instruction. Follow the manufacturer's information for a finished topical product.
View preparationCheck sources
More factsPeptide · Skin & cosmetics
Classification
Peptide · Skin & cosmetics
Research focus
Primarily a cosmetic ingredient. Marketing around wrinkles or expression lines is not an approved medicinal effect.
Evidence
Preclinical
Status
Not FDA/EMA approved

No generally accepted approved dose exists. Online amounts vary by material, purity, route and source and prove neither safety nor efficacy.

Schedule explained in detailCommunity/research information only

Amount status

No reference page and no approved injectable dose. SNAP-8/Acetyl Octapeptide-3 is a cosmetic ingredient, not a validated botulinum toxin substitute.

Profile evidence level: preclinical.

Timing

Only per the label of a finished topical formulation; not on injured/inflamed skin or near the eye.

No individual recommendation.

Cycle/duration

No independently validated cycle; studies of finished blend products do not establish the effect of the isolated substance.

No individual recommendation.

Mixing & calculations

There is no general injection-mixing instruction. Follow the manufacturer's information for a finished topical product.

All preparation informationProduct details and calculation examples from the available sources.

No systemic reconstitution or U-100 table. Topical concentration and storage are product-specific.

Reconstitution & quantitiesOpen basics, units and sources
Explained in very simple termsBefore reading any number: this page reports what a product label, study or online community states. It does not say what any person should use.

Amount

mg or µg describe the mass of a substance. That is not the same as ml of fluid or U on a syringe. The number is only the amount stated by the identified source.

Interval

The interval only describes the time stated between two points. For example, once every 7 days does not mean daily and never justifies catching up or doubling.

Cycle

A cycle is a stated period that may include breaks. A community cycle proves neither effectiveness nor safety and does not prevent long-term risks.

Reconstitution

Reconstitution means mixing powder with a defined volume of fluid. This changes concentration, not the total amount in the vial. On U-100, 100 U equals exactly 1 ml of volume.

Not a guide to misuse

All community figures are shown only to place widely circulated online protocols in context. They are not instructions for self-use, injection, performance enhancement or any other misuse. Approved figures apply only to the exact named product, approved indication and medical supervision.

Research, risks & more detailsMechanism, adverse effects, storage, comparisons and common questions.

Mechanism: what is supported and what does not follow

Synthetic cosmetic octapeptide marketed around expression-line appearance

SNAP-8 is classified as “Synthetic cosmetic octapeptide marketed around expression-line appearance”. Primarily a cosmetic ingredient. Marketing around wrinkles or expression lines is not an approved medicinal effect. This describes the investigated pathway but does not validate a community use, amount, route or combination.

01

Cosmetic octapeptide

This studies how an eight-amino-acid peptide might act on wrinkle formation or skin structure in skin models, comparable to testing how a cream affects the skin surface. Skin moisture and collagen markers are typically measured in cosmetic studies.

02

Neuromuscular cosmetic signalling

This studies how a substance affects the signal between nerves and small facial muscles, which can influence the appearance of expression lines, similar to briefly dimming a signal on a wire rather than cutting it. Researchers typically measure muscle activity and skin surface changes in cosmetic studies.

03

Skin matrix signalling

This examines how signals affect collagen and other structural proteins that give skin its firmness and elasticity, similar to studying the scaffolding beneath a building's surface. Researchers typically measure collagen production and skin structure in laboratory skin models.

What communities discuss

These themes describe discussions and vendor claims. They do not prove benefit, safety, product identity or suitable use.

Vendor marketing claims

Vendors often advertise products with broad efficacy claims, comparison tables against competitors, and customer quotes. Such marketing statements are driven by sales interest and do not constitute independent scientific proof of efficacy.

Skin and hair anecdotes

Users exchange personal impressions of skin appearance, wrinkle depth, or hair growth after using cosmetically marketed peptides, usually based on their own photos rather than measurement devices. Such subjective impressions and marketing claims are not proof of a confirmed effect.

Source and purity discussion

Discussion covers which vendors are seen as more trustworthy and how purity test results differ between batches. Such community assessments are based on limited samples and do not replace independent lab testing of each individual batch.

Adverse effects and safety risks

  • Topical substances can irritate, sensitise or cause contact allergy; injection or an unclear form greatly increases systemic, sterility and contamination risks.
  • Local reaction, infection, abscess and contamination are possible with any injection that is not professionally manufactured and administered.
  • A label or clear appearance does not exclude unknown purity, wrong identity, endotoxins or concentration errors.

Do not self-use / obtain clinical review

  • Open or infected skin, known allergies, pregnancy and unexplained skin changes should be assessed professionally before cosmetic or medical use.
  • Acute symptoms, allergic reaction, breathing difficulty, chest pain, neurological deficits or severe abdominal pain require immediate medical care.
  • Children and adolescents, pregnancy/breastfeeding, and people with relevant disease should not be part of unsupervised experiments.

Monitoring and laboratory markers

  • Skin reaction, documented area/concentration and stopping on irritation are more relevant than blood tests; systemic use requires separate medical assessment.
  • Baseline, objective, measurement timing and stop criteria must be defined professionally in advance. Individual laboratory values cannot compensate for unknown product quality.

Evidence boundary

Preclinical

Marketing around wrinkles or expression lines is not an approved medicinal effect.

Clinical evidence

Available data come mostly from animal or cell models; robust human efficacy and safety data are lacking.

SNAP-8 is primarily a cosmetic ingredient for topical use, not a systemically studied research peptide like GHK-Cu.

Storage and stability

  • The manufacturer label and prescribing information take priority. Storage instructions from a different product do not transfer.
  • Unapproved vials often lack dependable stability data before and after mixing; ‘2–8 °C’ or ‘28 days’ is not a universal standard.
  • Do not use after seal damage, particles, cloudiness, discoloration, unknown date or interrupted cold chain. Visual inspection does not prove sterility.

Troubleshooting and common errors

  • U-100 units measure volume, not drug amount: 100 U equals 1 mL. A wrong concentration makes every unit figure wrong.
  • Do not shake or dilute further to ‘fix’ cloudiness, particles or uncertain solubility; discard and obtain professional clarification.
  • Do not calculate a double or extra amount to compensate for missed use or an uncertain injection.
  • Without a COA, clear supplier, correct label and consistent vial information, identity is not confirmed.

Regulatory status and WADA

Not FDA/EMA approved

No FDA- or EMA-approved medicinal product; efficacy and safety are not established.

WADA 2026

The atlas has no explicit WADA flag for this profile. That does not automatically mean every form, route or related class is permitted in sport.

WADA — 2026 Prohibited List

Combinations / stacks

  • Combinations change effects, adverse effects and laboratory values; evidence for one substance does not establish the safety of a stack.
  • Overlapping pathways may add up. Hormonal, glucose, blood-pressure, coagulation, immune and sedating effects are important potential interactions.
  • Non-standardised blends prevent separate dosing, cause attribution and dependable reconstitution.

Frequently asked questions

Is an amount shown here a recommendation?

No. This page separates approved product information, study protocols and community information. No number or calculator is an individual dosing recommendation.

Does the U-100 calculator prove correct use?

No. It only converts mass, volume and syringe scale. It cannot check identity, purity, sterility, stability, solvent or medical suitability.

Can this profile be combined with other substances?

Safety of a combination cannot be inferred from a single-substance profile. Overlapping pathways, medicines and undefined blends can increase risk.

Which source controls when information conflicts?

For approved medicines, the current prescribing information and treating professional control. For research substances, conflict shows that no dependable self-use standard exists.

Are community claims clinical evidence?

No. Anecdotes can generate questions but do not replace controlled studies, regulatory review, or identity and quality testing.

Back to all 64 profilesOpen scientific atlas profile